Purpose of Review Liposomal delivery systems have gained significant attention in recent years for enhancing the bioavailability and efficacy of nutraceuticals. By encapsulating bioactive compounds in lipid bilayers, liposomal formulations can improve the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of nutraceuticals, overcoming challenges such as poor solubility, stability, and rapid degradation. This review provides a broad overview of the pharmacokinetic and pharmacodynamic insights related to liposomal nutraceutical formulations. Recent Finding In nutraceutical formulation, pharmacokinetic (PK) and pharmacodynamic (PD) investigations are essential because they ensure the product's safety, effectiveness, and peak performance. To improve bioavailability and establish the optimal dosage, PK studies focus on how the body absorbs, distributes, metabolizes, and excretes the active components. When combined, PK and PD data aid in the creation of formulations that minimize adverse effects while providing the desired health benefits. By determining how each individual responds to nutraceuticals, they also support personalized nutrition by guiding more accurate and useful recommendations. Ultimately, this research is critical for developing consumer-safe and effective nutraceuticals. It highlights how liposome size, composition, surface charge, and administration route influence absorption, distribution, metabolism, and excretion (ADME) processes. Recent studies have significantly advanced our understanding of pharmacokinetics (PK) and pharmacodynamics (PD) of liposomal formulations, particularly in enhancing drug delivery and therapeutic efficacy which includes Intracellular Distribution and Efficacy, Theranostic Applications and Dose Optimization in Infectious Diseases. Summary Review discusses the current challenges in translating liposomal nutraceuticals from preclinical studies to clinical applications and offers perspectives on future developments in this rapidly evolving field. Understanding the PK and PD characteristics of liposomal formulations is crucial for optimizing nutraceutical delivery and achieving better health outcomes. These findings underscore the evolving landscape of liposomal drug delivery systems, emphasizing the importance of PK/PD modeling in developing effective treatments across various medical conditions.

Pharmacokinetic and Pharmacodynamic Insights of Bioactive Molecules Encapsulated in Liposomal Formulation

期刊论文
发表日期：

2025年4月2日

查看全文

Preetha Balakrishnan,
Sreerag Gopi

摘要

Purpose of Review

Liposomal delivery systems have gained significant attention in recent years for enhancing the bioavailability and efficacy of nutraceuticals. By encapsulating bioactive compounds in lipid bilayers, liposomal formulations can improve the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of nutraceuticals, overcoming challenges such as poor solubility, stability, and rapid degradation. This review provides a broad overview of the pharmacokinetic and pharmacodynamic insights related to liposomal nutraceutical formulations.

Recent Finding

In nutraceutical formulation, pharmacokinetic (PK) and pharmacodynamic (PD) investigations are essential because they ensure the product's safety, effectiveness, and peak performance. To improve bioavailability and establish the optimal dosage, PK studies focus on how the body absorbs, distributes, metabolizes, and excretes the active components. When combined, PK and PD data aid in the creation of formulations that minimize adverse effects while providing the desired health benefits. By determining how each individual responds to nutraceuticals, they also support personalized nutrition by guiding more accurate and useful recommendations. Ultimately, this research is critical for developing consumer-safe and effective nutraceuticals. It highlights how liposome size, composition, surface charge, and administration route influence absorption, distribution, metabolism, and excretion (ADME) processes. Recent studies have significantly advanced our understanding of pharmacokinetics (PK) and pharmacodynamics (PD) of liposomal formulations, particularly in enhancing drug delivery and therapeutic efficacy which includes Intracellular Distribution and Efficacy, Theranostic Applications and Dose Optimization in Infectious Diseases.

Summary

Review discusses the current challenges in translating liposomal nutraceuticals from preclinical studies to clinical applications and offers perspectives on future developments in this rapidly evolving field. Understanding the PK and PD characteristics of liposomal formulations is crucial for optimizing nutraceutical delivery and achieving better health outcomes. These findings underscore the evolving landscape of liposomal drug delivery systems, emphasizing the importance of PK/PD modeling in developing effective treatments across various medical conditions.